Stock Price
1.03
Daily Change
0.01 0.98%
Monthly
31.29%
Yearly
-44.32%
Q2 Forecast
1.00

RedHill Biopharma reported $-1.31 in EPS Earnings Per Share for its fiscal quarter ending in June of 2024.





Eps Change Date
Cara Therapeutics USD -0.59 4.45 Sep/2025
Clal Biotechnology ILS -0.04 0.1 Dec/2022
Compugen USD 0.59 0.67 Dec/2025
Cronos Group USD 0.04 0.02 Mar/2026
RedHill Biopharma USD -1.31 33.38 Jun/2024